@inproceedings{dao-etal-2026-prionner,
title = "{P}rion{NER}: A Named Entity Recognition Dataset for Prion Disease Biomedical Literature",
author = "Dao, An and
Ly, Nhan and
Tran, Thao and
Matsumoto, Yuji and
Aizawa, Akiko",
editor = "Demner-Fushman, Dina and
Ananiadou, Sophia and
Roberts, Kirk and
Tsujii, Junichi",
booktitle = "{B}io{NLP} 2026",
month = jul,
year = "2026",
address = "San Diego, California",
publisher = "Association for Computational Linguistics",
url = "https://aclanthology.org/2026.bionlp-1.35/",
pages = "435--463",
ISBN = "979-8-89176-434-7",
abstract = "Prion diseases are rare, rapidly progressive, and fatal neurodegenerative disorders that remain difficult to diagnose, particularly in their early stages because of nonspecific clinical presentations. However, to our knowledge, there is no publicly available prion-disease-focused dataset designed to capture a broad range of clinically relevant entities from the biomedical literature. We introduce PrionNER, a manually annotated named entity recognition dataset for prion disease clinical information in PubMed abstracts. The current release comprises 317 abstracts, 2,943 sentences, and 6,955 text-bound entity annotations spanning 15 coarse-grained and 31 fine-grained clinically oriented entity types covering diseases, symptoms, diagnostics, findings, anatomy, treatments, and temporal and statistical evidence. Inter-annotator agreement reaches 81.78 exact-match F1, indicating strong annotation consistency. We benchmark supervised BERT baselines, W2NER, and zero-shot extractors on PrionNER. W2NER is the strongest supervised model, and Gemma-4-31B is the strongest zero-shot model, but the benchmark remains challenging, especially for structurally complex mentions and fine-grained clinically adjacent label distinctions. PrionNER provides a clinically grounded benchmark for prion-disease information extraction and supports research on rare-disease biomedical NLP under low-resource, fine-grained, and non-flat extraction conditions. The dataset, annotation guidelines, and evaluation scripts are available at https://github.com/daotuanan/PrionNER/"
}<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3">
<mods ID="dao-etal-2026-prionner">
<titleInfo>
<title>PrionNER: A Named Entity Recognition Dataset for Prion Disease Biomedical Literature</title>
</titleInfo>
<name type="personal">
<namePart type="given">An</namePart>
<namePart type="family">Dao</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nhan</namePart>
<namePart type="family">Ly</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Thao</namePart>
<namePart type="family">Tran</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yuji</namePart>
<namePart type="family">Matsumoto</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Akiko</namePart>
<namePart type="family">Aizawa</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<originInfo>
<dateIssued>2026-07</dateIssued>
</originInfo>
<typeOfResource>text</typeOfResource>
<relatedItem type="host">
<titleInfo>
<title>BioNLP 2026</title>
</titleInfo>
<name type="personal">
<namePart type="given">Dina</namePart>
<namePart type="family">Demner-Fushman</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sophia</namePart>
<namePart type="family">Ananiadou</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Kirk</namePart>
<namePart type="family">Roberts</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Junichi</namePart>
<namePart type="family">Tsujii</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<originInfo>
<publisher>Association for Computational Linguistics</publisher>
<place>
<placeTerm type="text">San Diego, California</placeTerm>
</place>
</originInfo>
<genre authority="marcgt">conference publication</genre>
<identifier type="isbn">979-8-89176-434-7</identifier>
</relatedItem>
<abstract>Prion diseases are rare, rapidly progressive, and fatal neurodegenerative disorders that remain difficult to diagnose, particularly in their early stages because of nonspecific clinical presentations. However, to our knowledge, there is no publicly available prion-disease-focused dataset designed to capture a broad range of clinically relevant entities from the biomedical literature. We introduce PrionNER, a manually annotated named entity recognition dataset for prion disease clinical information in PubMed abstracts. The current release comprises 317 abstracts, 2,943 sentences, and 6,955 text-bound entity annotations spanning 15 coarse-grained and 31 fine-grained clinically oriented entity types covering diseases, symptoms, diagnostics, findings, anatomy, treatments, and temporal and statistical evidence. Inter-annotator agreement reaches 81.78 exact-match F1, indicating strong annotation consistency. We benchmark supervised BERT baselines, W2NER, and zero-shot extractors on PrionNER. W2NER is the strongest supervised model, and Gemma-4-31B is the strongest zero-shot model, but the benchmark remains challenging, especially for structurally complex mentions and fine-grained clinically adjacent label distinctions. PrionNER provides a clinically grounded benchmark for prion-disease information extraction and supports research on rare-disease biomedical NLP under low-resource, fine-grained, and non-flat extraction conditions. The dataset, annotation guidelines, and evaluation scripts are available at https://github.com/daotuanan/PrionNER/</abstract>
<identifier type="citekey">dao-etal-2026-prionner</identifier>
<location>
<url>https://aclanthology.org/2026.bionlp-1.35/</url>
</location>
<part>
<date>2026-07</date>
<extent unit="page">
<start>435</start>
<end>463</end>
</extent>
</part>
</mods>
</modsCollection>
%0 Conference Proceedings
%T PrionNER: A Named Entity Recognition Dataset for Prion Disease Biomedical Literature
%A Dao, An
%A Ly, Nhan
%A Tran, Thao
%A Matsumoto, Yuji
%A Aizawa, Akiko
%Y Demner-Fushman, Dina
%Y Ananiadou, Sophia
%Y Roberts, Kirk
%Y Tsujii, Junichi
%S BioNLP 2026
%D 2026
%8 July
%I Association for Computational Linguistics
%C San Diego, California
%@ 979-8-89176-434-7
%F dao-etal-2026-prionner
%X Prion diseases are rare, rapidly progressive, and fatal neurodegenerative disorders that remain difficult to diagnose, particularly in their early stages because of nonspecific clinical presentations. However, to our knowledge, there is no publicly available prion-disease-focused dataset designed to capture a broad range of clinically relevant entities from the biomedical literature. We introduce PrionNER, a manually annotated named entity recognition dataset for prion disease clinical information in PubMed abstracts. The current release comprises 317 abstracts, 2,943 sentences, and 6,955 text-bound entity annotations spanning 15 coarse-grained and 31 fine-grained clinically oriented entity types covering diseases, symptoms, diagnostics, findings, anatomy, treatments, and temporal and statistical evidence. Inter-annotator agreement reaches 81.78 exact-match F1, indicating strong annotation consistency. We benchmark supervised BERT baselines, W2NER, and zero-shot extractors on PrionNER. W2NER is the strongest supervised model, and Gemma-4-31B is the strongest zero-shot model, but the benchmark remains challenging, especially for structurally complex mentions and fine-grained clinically adjacent label distinctions. PrionNER provides a clinically grounded benchmark for prion-disease information extraction and supports research on rare-disease biomedical NLP under low-resource, fine-grained, and non-flat extraction conditions. The dataset, annotation guidelines, and evaluation scripts are available at https://github.com/daotuanan/PrionNER/
%U https://aclanthology.org/2026.bionlp-1.35/
%P 435-463
Markdown (Informal)
[PrionNER: A Named Entity Recognition Dataset for Prion Disease Biomedical Literature](https://aclanthology.org/2026.bionlp-1.35/) (Dao et al., BioNLP 2026)
ACL